187 related articles for article (PubMed ID: 15599103)
1. New perspectives in the studies on endocannabinoid and cannabis: abnormal behaviors associate with CB1 cannabinoid receptor and development of therapeutic application.
Fujiwara M; Egashira N
J Pharmacol Sci; 2004 Dec; 96(4):362-6. PubMed ID: 15599103
[TBL] [Abstract][Full Text] [Related]
2. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
[TBL] [Abstract][Full Text] [Related]
3. The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide.
Mallet PE; Beninger RJ
Psychopharmacology (Berl); 1998 Nov; 140(1):11-9. PubMed ID: 9862397
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats.
Carta G; Nava F; Gessa GL
Brain Res; 1998 Oct; 809(1):1-4. PubMed ID: 9795096
[TBL] [Abstract][Full Text] [Related]
5. The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors.
Moreno-Martet M; Feliú A; Espejo-Porras F; Mecha M; Carrillo-Salinas FJ; Fernández-Ruiz J; Guaza C; de Lago E
Mult Scler Relat Disord; 2015 Nov; 4(6):505-11. PubMed ID: 26590655
[TBL] [Abstract][Full Text] [Related]
6. Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons.
Sano K; Mishima K; Koushi E; Orito K; Egashira N; Irie K; Takasaki K; Katsurabayashi S; Iwasaki K; Uchida N; Egawa T; Kitamura Y; Nishimura R; Fujiwara M
Neuroscience; 2008 Jan; 151(2):320-8. PubMed ID: 18083311
[TBL] [Abstract][Full Text] [Related]
7. SR 141716A differentially attenuates the behavioral effects of delta9-THC in rhesus monkeys.
McMahon LR; Amin MR; France CP
Behav Pharmacol; 2005 Sep; 16(5-6):363-72. PubMed ID: 16148440
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.
Pryce G; Riddall DR; Selwood DL; Giovannoni G; Baker D
J Neuroimmune Pharmacol; 2015 Jun; 10(2):281-92. PubMed ID: 25537576
[TBL] [Abstract][Full Text] [Related]
9. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
Pertwee RG
Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
[TBL] [Abstract][Full Text] [Related]
10. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.
Zimmer A; Zimmer AM; Hohmann AG; Herkenham M; Bonner TI
Proc Natl Acad Sci U S A; 1999 May; 96(10):5780-5. PubMed ID: 10318961
[TBL] [Abstract][Full Text] [Related]
11. Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.
Springs AE; Karmaus PW; Crawford RB; Kaplan BL; Kaminski NE
J Leukoc Biol; 2008 Dec; 84(6):1574-84. PubMed ID: 18791168
[TBL] [Abstract][Full Text] [Related]
12. THC-induced behavioral stereotypy in zebrafish as a model of psychosis-like behavior.
Dahlén A; Zarei M; Melgoza A; Wagle M; Guo S
Sci Rep; 2021 Aug; 11(1):15693. PubMed ID: 34344922
[TBL] [Abstract][Full Text] [Related]
13. Involvement of reduced acetylcholine release in Delta9-tetrahydrocannabinol-induced impairment of spatial memory in the 8-arm radial maze.
Mishima K; Egashira N; Matsumoto Y; Iwasaki K; Fujiwara M
Life Sci; 2002 Dec; 72(4-5):397-407. PubMed ID: 12467880
[TBL] [Abstract][Full Text] [Related]
14. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat.
Cox ML; Welch SP
Eur J Pharmacol; 2004 Jun; 493(1-3):65-74. PubMed ID: 15189765
[TBL] [Abstract][Full Text] [Related]
15. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
[TBL] [Abstract][Full Text] [Related]
16. Delta9-Tetrahydrocannabinol-induced cognitive deficits are reversed by olanzapine but not haloperidol in rats.
Egashira N; Ishigami N; Mishima K; Iwasaki K; Oishi R; Fujiwara M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):499-506. PubMed ID: 18029074
[TBL] [Abstract][Full Text] [Related]
17. Activation of CB
Joffre J; Yeh CC; Wong E; Thete M; Xu F; Zlatanova I; Lloyd E; Kobzik L; Legrand M; Hellman J
J Immunol; 2020 Jun; 204(12):3339-3350. PubMed ID: 32385136
[No Abstract] [Full Text] [Related]
18. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
[TBL] [Abstract][Full Text] [Related]
19. A novel component of cannabis extract potentiates excitatory synaptic transmission in rat olfactory cortex in vitro.
Whalley BJ; Wilkinson JD; Williamson EM; Constanti A
Neurosci Lett; 2004 Jul; 365(1):58-63. PubMed ID: 15234473
[TBL] [Abstract][Full Text] [Related]
20. Metabolic memory of Δ9-tetrahydrocannabinol exposure in pluripotent stem cells and primordial germ cells-like cells.
Verdikt R; Armstrong AA; Cheng J; Hwang YS; Clark AT; Yang X; Allard P
Elife; 2023 Dec; 12():. PubMed ID: 38150302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]